518 related articles for article (PubMed ID: 32985688)
1. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation.
Hasegawa K; Fujii S; Matsumoto S; Tajiri Y; Kikuchi A; Kiyoshima T
J Pathol; 2021 Jan; 253(1):80-93. PubMed ID: 32985688
[TBL] [Abstract][Full Text] [Related]
2. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
Hiemer SE; Zhang L; Kartha VK; Packer TS; Almershed M; Noonan V; Kukuruzinska M; Bais MV; Monti S; Varelas X
Mol Cancer Res; 2015 Jun; 13(6):957-68. PubMed ID: 25794680
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
Ahmad US; Parkinson EK; Wan H
Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Kank1 expression regulates YAP to promote apoptosis and inhibit proliferation in OSCC.
Fan H; Tian H; Cheng X; Chen Y; Liang S; Zhang Z; Liao Y; Xu P
J Cell Physiol; 2020 Feb; 235(2):1850-1865. PubMed ID: 31338836
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
7. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma.
Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H
Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049
[TBL] [Abstract][Full Text] [Related]
8. Malic Enzyme 1 Is Associated with Tumor Budding in Oral Squamous Cell Carcinomas.
Nakashima C; Kirita T; Yamamoto K; Mori S; Luo Y; Sasaki T; Fujii K; Ohmori H; Kawahara I; Mori T; Goto K; Kishi S; Fujiwara-Tani R; Kuniyasu H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998265
[TBL] [Abstract][Full Text] [Related]
9. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
[TBL] [Abstract][Full Text] [Related]
10. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma.
Zhang L; Ye DX; Pan HY; Wei KJ; Wang LZ; Wang XD; Shen GF; Zhang ZY
Oral Oncol; 2011 Aug; 47(8):693-7. PubMed ID: 21708480
[TBL] [Abstract][Full Text] [Related]
11. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
12. From the Matrix to the Nucleus and Back: Mechanobiology in the Light of Health, Pathologies, and Regeneration of Oral Periodontal Tissues.
Dieterle MP; Husari A; Steinberg T; Wang X; Ramminger I; Tomakidi P
Biomolecules; 2021 May; 11(6):. PubMed ID: 34073044
[TBL] [Abstract][Full Text] [Related]
13. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
[TBL] [Abstract][Full Text] [Related]
14. Piezo1 impairs hepatocellular tumor growth via deregulation of the MAPK-mediated YAP signaling pathway.
Liu S; Xu X; Fang Z; Ning Y; Deng B; Pan X; He Y; Yang Z; Huang K; Li J
Cell Calcium; 2021 May; 95():102367. PubMed ID: 33610907
[TBL] [Abstract][Full Text] [Related]
15. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
[TBL] [Abstract][Full Text] [Related]
16. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma.
Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L
J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796
[TBL] [Abstract][Full Text] [Related]
17. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation.
Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y
Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042
[TBL] [Abstract][Full Text] [Related]
18. The role of YAP in the control of the metastatic potential of oral cancer.
Ahmad US; Saravanan K; Wan H
Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
[TBL] [Abstract][Full Text] [Related]
19. The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation.
Fujii S; Tajiri Y; Hasegawa K; Matsumoto S; Yoshimoto RU; Wada H; Kishida S; Kido MA; Yoshikawa H; Ozeki S; Kiyoshima T
Lab Invest; 2020 Feb; 100(2):311-323. PubMed ID: 31857698
[TBL] [Abstract][Full Text] [Related]
20. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]